KINTOR PHARMA-B (09939.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Sep8

Kintai Therapeutics Completes Enrollment for KT-939 Long-Term Safety Trial

22:19

Aug28

Kehua Pharmaceutical-B Announces Wider Loss in Semi-annual Results

15:59

KINTOR PHARMA-B released FY2025 Q1 earnings on August 28, 2025 (BJT) with actual revenue of HKD 3.204 M and EPS of HKD -0.1027

15:00

KINTOR PHARMA-B released FY2025 Q2 earnings on August 28 After-Market (BJT), actual revenue HKD 3.275 M, actual EPS HKD -0.1049

11:00

KINTOR PHARMA-B released FY2025 Semi-Annual earnings on August 28 After-Market (BJT), actual revenue HKD 6.479 M, actual EPS HKD -0.2077

11:00

Aug20

KINTOR PHARMA-B to Release FY2025 Semi-Annual Earnings on August 28, 2025 (BJT)

01:57

Schedules & Filings

Schedules

Filings

Aug28

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 3.275 M, Net Income -45.57 M, EPS -0.1049

Mar26

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 2.66 M, Net Income -44.57 M, EPS -0.1034

Aug26

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Net Income -38.41 M, EPS -0.0892

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change